Current Research in Pharmacology and Drug Discovery

Metadata for this journal is being automatically enriched from connected scholarly data sources.

Journal information

Publisher

Elsevier

Subjects

Asthma and respiratory diseases · Big Data and Digital Economy · Computational Drug Discovery Methods · COVID-19 Clinical Research Studies · Diverse Scientific and Economic Studies · drug action · drug discovery · Ferroelectric and Negative Capacitance Devices · Inflammatory Bowel Disease · pharmacogenetics · pharmacology · pharmacotherapy · RM1-950 · SARS-CoV-2 and COVID-19 Research · Therapeutics. Pharmacology

Country

NL

Languages

EN

ISSN

2590-2571

E-ISSN

2590-2571

ISSN-L

2590-2571

Open access

Yes

OA since

2020

Publication years

2020–2026

APC (summary)

—

Website

Visit journal ↗

Journal Classification

Classification is derived from this journal’s 2024–2025 publications using the OpenAlex taxonomy.

Classification

Field / Subfield

Primary Field

Medicine

Primary Subfield

Oncology

Domain

Health Sciences

Confidence

Low

Publications classified

68

Classification version

OAJF Classification v1.1

APC records

OPENALEX · 2026

2,510 EUR

OPENALEX · 2026

2,150 GBP

OPENALEX · 2026

332,400 JPY

OPENALEX · 2026

2,680 USD

DOAJ · 2026

3,280 USD